ELCO Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7K | Buy |
16,200
+1,300
| +9% | +$1.18K | 0.01% | 156 |
|
|
2025
Q1 | $6.73K | Hold |
14,900
| – | – | ﹤0.01% | 155 |
|
|
2024
Q4 | $7.49K | Buy |
14,900
+2,900
| +24% | +$1.46K | ﹤0.01% | 158 |
|
|
2024
Q3 | $10.9K | Hold |
12,000
| – | – | 0.01% | 163 |
|
|
2024
Q2 | $12K | Hold |
12,000
| – | – | 0.01% | 156 |
|
|
2024
Q1 | $17.8K | Hold |
12,000
| – | – | 0.01% | 154 |
|
|
2023
Q4 | $13.1K | Hold |
12,000
| – | – | 0.01% | 142 |
|
|
2023
Q3 | $14.2K | Hold |
12,000
| – | – | 0.01% | 135 |
|
|
2023
Q2 | $16.9K | Hold |
12,000
| – | – | 0.01% | 128 |
|
|
2023
Q1 | $18K | Hold |
12,000
| – | – | 0.01% | 136 |
|
|
2022
Q4 | $16.7K | Hold |
12,000
| – | – | 0.01% | 137 |
|
|
2022
Q3 | $14K | Buy |
+12,000
| New | +$14K | 0.01% | 139 |
|